Skip to content

Sucrose Analgesia in Infants Undergoing Casting for Club Foot

Effectiveness of Sucrose Analgesia in Infants Undergoing Casting for Club Foot

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01050088
Acronym
SCF
Enrollment
20
Registered
2010-01-15
Start date
2010-03-31
Completion date
2011-03-31
Last updated
2010-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clubfoot

Keywords

clubfoot, casting, ponseti, discomfort

Brief summary

Babies with congenital clubfeet are treated by the Ponseti casting method. The procedure may cause discomfort to the patient. This study will examine the use of 5 CC Sucrose solution as a comforting agent for the babies.

Detailed description

Babies who were born with congenital clubfeet are currently being treated by the conventional Ponseti method. This procedure is done in an outpatient clinic setup. The procedure is painless but may cause some discomfort to the patient. This study will examine the use of 5 CC Sucrose solution as a comforting agent for the babies. The control group will consist of patients who will get 5cc saline pre cast application, while the study group will be given 5cc of Sucrose solution. Patients and physicians are blinded to the treatment they get. Outcome measures will include pulse rate and oxygenation as an accepted measure of discomfort.

Interventions

DIETARY_SUPPLEMENTsucrose solution

5cc 5% sucrose solution P/O

DIETARY_SUPPLEMENTSaline

5cc saline p/o

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Weeks to 12 Months
Healthy volunteers
No

Inclusion criteria

* All otherwise healthy babies who need casting for congenital clubfeet

Exclusion criteria

* All non idiopathic conditions for clubfoot, all individuals who have any kind of known systemic illness, all babies born to diabetic mothers.

Design outcomes

Primary

MeasureTime frame
Pulse rate, Blood oxygenationDuring casting

Countries

Israel

Contacts

Primary ContactDaniel M Weigl, MD
danielw@clalit.org.il972-3-9253759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026